540788 — Aspira Pathlab & Diagnostics Income Statement
0.000.00%
Last trade - 00:00- IN₹310.33m
- IN₹319.87m
- IN₹144.57m
Annual income statement for Aspira Pathlab & Diagnostics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 76.4 | 84.2 | 152 | 195 | 145 |
| Cost of Revenue | |||||
| Gross Profit | 53.8 | 64.3 | 126 | 164 | 120 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 121 | 119 | 131 | 148 | 144 |
| Operating Profit | -44.8 | -34.9 | 20.7 | 47.4 | 0.076 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -51.8 | -42.1 | 13.8 | 44.6 | -0.887 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -51.8 | -42.4 | 13.8 | 44.6 | -0.887 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -51.8 | -42.4 | 13.8 | 44.6 | -0.887 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -51.8 | -42.4 | 13.8 | 44.6 | -0.887 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -6.33 | -4.95 | 1.45 | 4.33 | -0.086 |